307180
Reducing Disparities in Timely Autism Diagnosis through Family Navigation
Families were randomized into either standard care or family navigation. Those with family navigation received individualized care to help overcome barriers to completing the diagnostic assessment. Primary outcomes were time to diagnosis, parental stress, and parent satisfaction with diagnostic process. Families were assessed at baseline and three-months after their last clinic visit or two weeks after their final scheduled appointment.
We have randomized 37 out of an expected 40 children-parent dyads. The two groups were demographically similar; children were 75% male; 65% non-white; and average 2.6 years old; (89%) qualified as low-income. All intervention families had minimum one visit with a navigator, with an average of 7.5 encounters. To date, 13 of 15 families (87%) who received navigation, compared to 6 of the 18 families (33%) who received standard care, completed the developmental assessment. Analysis of the trial is ongoing.
This novel, easily replicated program demonstrates the feasibility and acceptability of patient navigation in the pre-diagnostic setting for low-income and minority families, and suggests possible benefits to decreased time to diagnosis.
Learning Areas:
Implementation of health education strategies, interventions and programsLearning Objectives:
Discuss the feasibility of using patient navigators to decrease the delays in diagnosing minority and low-income children identified as at-risk for Autism Spectrum Disorder (ASD).
Keyword(s): Children With Special Needs, Health Disparities/Inequities
Qualified on the content I am responsible for because: As the Project Manager, I was responsible for identifying and enrolling 40 hard-to-reach study participants over an 18 month period. I also delivered the intervention in both Spanish and English. I am passionate about helping minority and low-income families identify and overcome barriers to accessing health care.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.